Package 58284-232-01
Brand: brixadi
Generic: buprenorphinePackage Facts
Identity
Package NDC
58284-232-01
Digits Only
5828423201
Product NDC
58284-232
Description
1 SYRINGE, GLASS in 1 CARTON (58284-232-01) / .64 mL in 1 SYRINGE, GLASS
Marketing
Marketing Status
Brand
brixadi
Generic
buprenorphine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "4e1985eb-1302-42e0-ac79-10b0a492966a", "openfda": {"nui": ["N0000175689", "N0000175685"], "unii": ["40D3SCR4GZ"], "rxcui": ["2639021", "2639027", "2639029", "2639030", "2639031", "2639032", "2639033", "2639034", "2639036", "2639039", "2639041", "2639042", "2639043", "2639044"], "spl_set_id": ["5d8a8fd0-8619-422a-a664-d1d2e8970f48"], "pharm_class_epc": ["Partial Opioid Agonist [EPC]"], "pharm_class_moa": ["Partial Opioid Agonists [MoA]"], "manufacturer_name": ["Braeburn Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (58284-232-01) / .64 mL in 1 SYRINGE, GLASS", "package_ndc": "58284-232-01", "marketing_start_date": "20230606"}], "brand_name": "BRIXADI", "product_id": "58284-232_4e1985eb-1302-42e0-ac79-10b0a492966a", "dosage_form": "INJECTION", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "58284-232", "dea_schedule": "CIII", "generic_name": "BUPRENORPHINE", "labeler_name": "Braeburn Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BRIXADI", "active_ingredients": [{"name": "BUPRENORPHINE", "strength": "32 mg/.64mL"}], "application_number": "NDA210136", "marketing_category": "NDA", "marketing_start_date": "20230606", "listing_expiration_date": "20271231"}